Sunday, October 20, 2019 5:30:14 PM
SUMMARY
As provided herein, ASC (e.g. placental ASC) are expanded in a serum-free medium. The resulting cells exhibit a unique set of characteristics and properties that are not believed to have any counterpart, either in nature or in previously-known artificially-produced cell compositions. They are, in some embodiments, induced as a result of the described ex-vivo expansion steps to produce or secrete elevated amounts of therapeutic factors. In still other embodiments, they are suitable for use in tissues distant from their site of administration, or, in other embodiments, when administered systemically.
https://patents.google.com/patent/WO2019186471A1/en?q=thermo+fisher&assignee=pluristem+Ltd&oq=pluristem+Ltd+thermo+fisher
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM